1. Bai, Zi-Yuan, Peng, Lu-Shan, Li, Run-Qi, Peng, Xianchu, Yang, Zhe. 2023. STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma. In Aging, 15, 11286-11297. doi:10.18632/aging.205127. https://pubmed.ncbi.nlm.nih.gov/37870765/
2. Saglam, Arzu, Cagdas, Deniz, Aydin, Burca, Katipoglu, Kubra, Uner, Aysegul. 2021. STK4 deficiency and EBV-associated lymphoproliferative disorders, emphasis on histomorphology, and review of literature. In Virchows Archiv : an international journal of pathology, 480, 393-401. doi:10.1007/s00428-021-03147-w. https://pubmed.ncbi.nlm.nih.gov/34604912/
3. López-Nevado, Marta, González-Granado, Luis I, Ruiz-García, Raquel, Neth, Olaf, Allende, Luis M. 2021. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. In Frontiers in immunology, 12, 671755. doi:10.3389/fimmu.2021.671755. https://pubmed.ncbi.nlm.nih.gov/34447369/
4. Jørgensen, Sofie E, Al-Mousawi, Ali, Assing, Kristian, Jakobsen, Marianne A, Mogensen, Trine H. 2020. STK4 Deficiency Impairs Innate Immunity and Interferon Production Through Negative Regulation of TBK1-IRF3 Signaling. In Journal of clinical immunology, 41, 109-124. doi:10.1007/s10875-020-00891-7. https://pubmed.ncbi.nlm.nih.gov/33078349/
5. Heallen, Todd, Zhang, Min, Wang, Jun, Johnson, Randy L, Martin, James F. . Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. In Science (New York, N.Y.), 332, 458-61. doi:10.1126/science.1199010. https://pubmed.ncbi.nlm.nih.gov/21512031/
6. Govorov, Igor, Attarha, Sanaz, Kovalevska, Larysa, Kashuba, Elena, Mints, Miriam. 2022. STK4 protein expression pattern follows different trends in endometrioid and serous endometrial adenocarcinoma upon tumor progression. In Scientific reports, 12, 22154. doi:10.1038/s41598-022-26391-9. https://pubmed.ncbi.nlm.nih.gov/36550267/
7. Yao, Weitao, Hou, Jingyu, Liu, Guoqing, Guo, Liangyu, Wang, Chuchu. . LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression. In Cancer biomarkers : section A of Disease markers, 36, 1-16. doi:10.3233/CBM-210291. https://pubmed.ncbi.nlm.nih.gov/35912730/
智鼠故事 
